More testing is needed, but if the same results are seen in humans, it could transform treatment of the disease.
The FDA has approved a new treatment for patients with a common form of breast cancer that has spread to other parts of the body or cannot be surgically removed.
Despite significant therapeutic advances, breast cancer remains a leading cause of cancer-related death in women. Treatment typically involves surgery and follow-up hormone therapy, but late effects ...
The true incidence of thrombosis among people who received targeted therapy for breast cancer is significantly higher than ...
The increase in breast cancer rates among younger patients is occurring as the incidence of other early-onset cancers — ...
It’s a sobering statistic: 1 in 8 women in the United States will be diagnosed with breast cancer during her lifetime.1 ...
Legacy projects can help someone with metastatic breast cancer leave behind a lasting impact that will be remembered after ...
Gabriela Dabrowski, international tennis doubles champion, thought breast lump suspicious, but doctors said otherwise. They ...
According to the American Cancer Society, there is an alarming new trend in reported cancer cases. In the U.S., there is a ...
The efficacy of immunotherapy against triple-negative breast cancer (TNBC) heavily relies on intratumoral infiltration of ...